Deanna Mudie, PhD

home / authors / deanna-mudie-phd

Deanna Mudie, PhD, is principal scientist, Lonza, Bend, OR, USA.

Articles

Enhanced Bioavailability of Acalabrutinib ASD Tablets In-Vivo

Deanna Mudie, PhD

August 31st 2021

The pH effect encountered with oral oncology medication can be overcome with amorphous solid dispersions.

ASD Tablets

In-Vivo Demonstration of Enhanced Bioavailability of Acalabrutinib ASD Tablets

Deanna Mudie, PhD

August 3rd 2021

Amorphous solid dispersions can overcome the pH effect encountered with oral oncology medications.

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

Published: August 21st 2024 | Updated: December 26th 2024

Pharmaceutical Technology Editorial Advisory Board

Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics

Published: November 25th 2024 | Updated: December 26th 2024

Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics

Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development

Published: December 20th 2024 | Updated: December 26th 2024

Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development

Europa Perspectives: Helping to Navigate the Regulatory System

Published: February 23rd 2024 | Updated: December 26th 2024

Europa Perspectives: Helping to Navigate the Regulatory System

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.